ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations.

Dublin, May 08, 2026 (GLOBE NEWSWIRE)-- The "Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...

In the global pharmaceutical manufacturing landscape, HK Neopharm Limited has been increasingly recognized by industry observers as a noteworthy participant in the active pharmaceutical ingredient ...

Pharmaceuticals are developed, designed, and commonly manufactured in laboratory settings. Laboratory testing is an essential need in almost every stage of pharmaceutical production and R&D, from the ...

NEW YORK, Sept. 12, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that MD Anderson ...

The US supply of generic drugs is heavily dependent on the global supply chain for sources of generic active pharmaceutical ingredients (APIs) for the US pharmaceutical market. Data from Clarivate ...

Recipharm is pleased to announce that it has signed an agreement with Daewoong, the leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year ...

India is a major generic drug supplier but remains highly dependent on China for APIs (imports $7.4B; 65–86% share). A recent report flags supply risk and the need to boost domestic API production.

ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...

(MENAFN- GlobeNewsWire - Nasdaq) The Global API market is expanding due to rising chronic diseases, demand for generics post-patent expirations, and R&D investments. There are opportunities in ...